ResearcherNorthwestern UniversityActive in the last 2 years

Cade F. Bennett

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-8195-2622; OpenAlex author ID A5006039485, A5130014805. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

A comparison of outcomes for patients with localized pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy with and without radiation prior to cu… Co-author DOI 10.21037/cco-25-60 ↗
Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and potential guidance to screening guidelines. Co-author DOI 10.1016/j.pan.2022.05.005 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Akhil Chawla · 2 shared papers, 2022–2025 · strength 0.53
- Paper A comparison of outcomes for patients with localized pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherap… DOI 10.21037/cco-25-60 ↗
- Paper Identification of high-risk germline variants for the development of pancreatic cancer: Common characteristics and pote… DOI 10.1016/j.pan.2022.05.005 ↗
Dominic J. Vitello · 1 shared paper, 2025 · strength 0.30
- Paper A comparison of outcomes for patients with localized pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherap… DOI 10.21037/cco-25-60 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.